BioWednesday: What Does the US-China Interface Mean for the Global Life Science Industry?

03/10/2021  |  17:00-19:00

Hybrid webinar in collaboration with One Nucleus.

In association with Fish & Richardson. With US and China being increasingly the main dominant source of investment for life science companies, how should companies balance their engagement? Furthermore, how do the broader US-China relations impact the flow of investment into other markets, such as the UK.

Mike Ward, Global Head of Thought Leadership, Clarivate (Moderator)
Chad Shear, Principal, Fish & Richardson
Simon Haworth, CEO, Dynasty Bio
Hayley French, CEO, Apitope
Yuehua Cong, Executive Director, Head of Europe, BD&L and Investment, Simcere Pharmaceutical Group

Please Note, there will be two ways of attending this event.

Delegates have the option of attending online or in-person, but not in the traditional hybrid format, as follows:
Content will be live streamed to multiple physical hubs and made available online with speakers remote from all locations and all delegates able to pose questions and comments throughout.

Previous Next
Test Caption
Test Description goes like this